NO159998C - Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat. - Google Patents

Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat.

Info

Publication number
NO159998C
NO159998C NO844895A NO844895A NO159998C NO 159998 C NO159998 C NO 159998C NO 844895 A NO844895 A NO 844895A NO 844895 A NO844895 A NO 844895A NO 159998 C NO159998 C NO 159998C
Authority
NO
Norway
Prior art keywords
preparation
new therapeutic
therapeutic active
sulphonamide derivative
analogy
Prior art date
Application number
NO844895A
Other languages
English (en)
Other versions
NO844895L (no
NO159998B (no
Inventor
Robert Michael Demarinis
Jacob Paul Hieble
Carl Kaiser
James William Wilson
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO844895L publication Critical patent/NO844895L/no
Publication of NO159998B publication Critical patent/NO159998B/no
Publication of NO159998C publication Critical patent/NO159998C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO844895A 1983-12-07 1984-12-06 Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat. NO159998C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/559,151 US4507320A (en) 1983-12-07 1983-12-07 Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine

Publications (3)

Publication Number Publication Date
NO844895L NO844895L (no) 1985-06-10
NO159998B NO159998B (no) 1988-11-21
NO159998C true NO159998C (no) 1989-03-01

Family

ID=24232466

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844895A NO159998C (no) 1983-12-07 1984-12-06 Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat.

Country Status (22)

Country Link
US (1) US4507320A (no)
EP (1) EP0147114B1 (no)
JP (1) JPS60139664A (no)
KR (1) KR850004586A (no)
AR (1) AR240555A1 (no)
AT (1) ATE26702T1 (no)
AU (1) AU565667B2 (no)
CA (1) CA1212959A (no)
DE (1) DE3463265D1 (no)
DK (1) DK550384A (no)
EG (1) EG16694A (no)
ES (2) ES8604497A1 (no)
FI (1) FI79836C (no)
GR (1) GR81145B (no)
HU (1) HU193722B (no)
IL (1) IL73471A (no)
NO (1) NO159998C (no)
NZ (1) NZ210053A (no)
PH (1) PH21807A (no)
PT (1) PT79618B (no)
ZA (1) ZA849459B (no)
ZW (1) ZW18784A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
US4629730A (en) * 1985-04-11 1986-12-16 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
ES8606847A1 (es) * 1984-11-08 1986-05-16 Syntex Inc Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
US4847269A (en) * 1985-04-11 1989-07-11 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4642378A (en) * 1985-04-11 1987-02-10 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
JP3312629B2 (ja) * 1991-01-23 2002-08-12 日産化学工業株式会社 アニリン誘導体及び製法
FR2724654B1 (fr) * 1994-09-16 1997-12-12 Roussel Uclaf Nouveaux derives de l'acide gallique, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
DE19842796A1 (de) * 1998-09-18 2000-03-30 Atochem Elf Deutschland Radikalbildner und Phlegmatisierungsmittel enthaltende Zusammensetzungen, Verwendungen und Verfahren zur Herstellung solcher Zusammensetzungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (no) * 1962-01-24
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
US3758692A (en) * 1969-04-14 1973-09-11 Mead Johnson & Co Ylamines sympathomimetic process and compositions employing sulfonamidophenalk
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts
US4219568A (en) * 1978-03-01 1980-08-26 University Patents, Inc. Method of increasing renal blood flow with dopamine derivatives
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals

Also Published As

Publication number Publication date
FI79836C (fi) 1990-03-12
GR81145B (en) 1985-04-04
ES8604497A1 (es) 1986-02-01
NZ210053A (en) 1987-06-30
HUT37744A (en) 1986-02-28
PT79618B (en) 1986-11-18
HU193722B (en) 1987-11-30
NO844895L (no) 1985-06-10
ES8606853A1 (es) 1986-05-01
AU3532484A (en) 1985-06-13
NO159998B (no) 1988-11-21
IL73471A (en) 1987-12-20
US4507320A (en) 1985-03-26
PT79618A (en) 1985-01-01
DK550384D0 (da) 1984-11-20
AU565667B2 (en) 1987-09-24
ATE26702T1 (de) 1987-05-15
PH21807A (en) 1988-02-29
AR240555A1 (es) 1990-05-31
KR850004586A (ko) 1985-07-25
ES548109A0 (es) 1986-05-01
ES538319A0 (es) 1986-02-01
FI844818A0 (fi) 1984-12-05
FI844818L (fi) 1985-06-08
EP0147114B1 (en) 1987-04-22
FI79836B (fi) 1989-11-30
ZA849459B (en) 1986-04-30
EG16694A (en) 1988-09-30
CA1212959A (en) 1986-10-21
ZW18784A1 (en) 1985-02-20
DE3463265D1 (de) 1987-05-27
JPS60139664A (ja) 1985-07-24
EP0147114A1 (en) 1985-07-03
DK550384A (da) 1985-06-08
IL73471A0 (en) 1985-02-28

Similar Documents

Publication Publication Date Title
NO164653C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt indol-derivat.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO167572C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO156525C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (3-aminopropoksy)bibenzylderivater.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO153099C (no) Analogifremgangsmaate for fremstilling av en terapeutisk virksom 5,5`-azobis-salicylsyre-forbindelse
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO159998C (no) Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat.
NO150762C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-aza-2-(2,2,2)-bicyklo-oktan
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO164416C (no) Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO159793C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-(4-arylcykloheksyl)-piperidinderivat.